BPH Global Advances Project Popeye Toward TGA Listing
| Stock | BPH Global Ltd (BP8.ASX) |
|---|---|
| Release Time | 19 Feb 2026, 9:59 a.m. |
| Price Sensitive | Yes |
BPH Global Advances Project Popeye Toward TGA Listing
- 'Project Popeye' confirmed as the Company's lead male vitality formulation initiative
- Proprietary marine-derived formulation incorporating tropical green seaweed species
- Product positioned for male vitality, anti-fatigue, stress recovery and sleep/wellness support
BPH Global Ltd (ASX: BP8) has provided an update on Project Popeye, its proprietary seaweed-based men's health supplement program. The company has now progressed to the final stages of completing the formulation, including confirmation of the specific ingredients and proportions. The formulation incorporates tropical green seaweed species Caulerpa lentillifera and Ulva lactuca, alongside complementary nutraceutical ingredients. The intended product is being developed as a natural over-the-counter supplement positioned to promote male vitality and general wellbeing, assist with energy and fatigue management, and contribute to stress recovery and healthy sleep balance. The company intends to apply for listing of the product on the Australian Register of Therapeutic Goods (ARTG) as a TGA-listed complementary medicine (AUST L). As part of its product validation strategy, the company has adopted a structured in-vitro, cell-based testing program designed to substantiate the biological activity of the Project Popeye formulation. The proposed testing program is expected to take approximately 3-5 months, followed by an additional one month for analysis and reporting. The company is currently in final discussions with Temasek Polytechnic, Singapore, to conduct this testing program. Over the coming weeks, the company expects to finalize the ingredient composition and proportions, confirm ingredient eligibility under the TGA permitted ingredients framework, execute the testing agreement with Temasek Polytechnic, and commence the cell-based testing program.
The company is seeking to establish a product platform capable of scaling into both domestic and international markets for the rapidly expanding global men's health and wellness sector, particularly in the natural and marine-derived nutraceutical category.